This review evaluated the efficacy of recombinant human growth hormone (rhGH), testosterone and anabolic steroids in the treatment of HIV wasting. The authors concluded that there were no significant differences between the treatments in their efficacy for increasing lean body mass, but an approved dose of rhGH may be advantageous in terms of functional capacity and quality of life. Given the methodology of the review, the reliability of the results and conclusions is uncertain.
Results of the review
Eighteen studies (n=1,792) were included in the review: 15 RCTs (one a crossover design) and 3 uncontrolled case series.
Ten of the included RCTs scored 3 or more on the Jadad scale out of a possible 5.
Body composition.
There was a statistically significant pre-post increase in LBM or FFM in people treated with rhGH (6 comparisons; MD 2.75, 95% CI: 1.44, 3.71), testosterone (5 comparisons; MD 1.93, 95% CI: 0.42, 3.45), testosterone/exercise (3 comparisons; MD 3.57, 95% CI: 2.30, 4.85), anabolic steroids (5 comparisons; MD 2.68, 95% CI: 2.06, 3.30), and combinations of oxandrolone with megestrol or testosterone/exercise (2 comparisons; MD 6.20, 95% CI: 4.93, 7.48). There was statistically significant heterogeneity in all but the anabolic steroids meta-analysis (P<0.10).
There was a statistically significant increase in LBM or FFM in people treated with rhGH (3 comparisons; MD 3.15, 95% CI: 2.68, 3.61), testosterone (2 comparisons; MD 2.91, 95% CI: 0.91, 4.92) or anabolic steroids (2 comparisons; MD 1.95, 95% CI: 0.52, 3.39), compared with placebo. There was no statistically significant heterogeneity in the metaanalysis of rhGH or anabolic steroid studies.
Safety.
There was no significant difference in mortality, the number of withdrawals, total adverse events, treatment-related adverse events, or hepatotoxicity withdrawals for patients treated with rhGH, testosterone, or anabolic steroids. There was a statistically significant increase in hepatotoxicity with anabolic steroids (OR 5.12, 95% CI: 1.68, 15.58) in comparison with placebo.
Physical function.
Two studies reported an improvement in work output in patients treated with rhGH. Two studies reported improved strength in some muscle groups when treated with testosterone or testosterone/exercise, compared with placebo. One study reported a significant increase in shoulder strength in patients treated with oxandrolone than in those given placebo. One study reported a significant increase in upper body strength and power, and knee power with rhGH, but a
